| P50 | author | Liliana Brambilla | Q38325050 |
| | Daniela Rossi | Q38325072 |
| | Adriana Maggi | Q54576643 |
| | Valeria Benedusi | Q61825035 |
| | Francesca Martorana | Q63651117 |
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | Structural basis for the activation of PPARgamma by oxidized fatty acids | Q27653525 |
| | Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 |
| | Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 |
| | Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures | Q28377342 |
| | Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation | Q29547561 |
| | Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle | Q29615169 |
| | Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS | Q30534614 |
| | Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways | Q33185412 |
| | Focal degeneration of astrocytes in amyotrophic lateral sclerosis. | Q33350786 |
| | The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta | Q33750688 |
| | Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice | Q33832905 |
| | Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice | Q33862624 |
| | Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. | Q34098992 |
| | Shared resistance to aging and ALS in neuromuscular junctions of specific muscles | Q34224953 |
| | Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration | Q34329795 |
| | Plasticity of the differentiated state | Q34379462 |
| | 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress | Q35104721 |
| | Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis | Q35166545 |
| | Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones | Q35242884 |
| | Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. | Q35564247 |
| | A lack of ovarian function increases neuroinflammation in aged mice | Q35986045 |
| | Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis | Q35987553 |
| | Dietary restriction attenuates age-associated muscle atrophy by lowering oxidative stress in mice even in complete absence of CuZnSOD. | Q36240273 |
| | Simplified nerve cell counting in the rat brainstem with the physical disector using a drawing-microscope. | Q36760708 |
| | PPARs and molecular mechanisms of transrepression | Q36791361 |
| | PPARs in the brain | Q36849598 |
| | Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders | Q36931609 |
| | Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. | Q37087752 |
| | Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model | Q37285915 |
| | Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia | Q37335663 |
| | Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities | Q37558528 |
| | Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond | Q37642283 |
| | Oxidative stress in ALS: key role in motor neuron injury and therapeutic target | Q37647061 |
| | Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α. | Q38844786 |
| | Lipoprotein lipase affects the survival and differentiation of neural cells exposed to very low density lipoprotein | Q40681158 |
| | The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells | Q40978148 |
| | Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis | Q41002046 |
| | Immortalization of immature and mature mouse astrocytes with SV40 T antigen. | Q41446266 |
| | Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons | Q41616019 |
| | Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus | Q41736276 |
| | Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation | Q42502038 |
| | Lower serum lipid levels are related to respiratory impairment in patients with ALS. | Q43240967 |
| | Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance | Q43258047 |
| | The peroxisome proliferator-activated receptor alpha-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain | Q43977411 |
| | Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis | Q44153760 |
| | Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-γ | Q44430549 |
| | Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden | Q44907890 |
| | Accumulation of protein-bound 4-hydroxy-2-hexenal in spinal cords from patients with sporadic amyotrophic lateral sclerosis | Q45015059 |
| | Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis | Q45223163 |
| | ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. | Q46135324 |
| | Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo | Q46525827 |
| | The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. | Q46667874 |
| | Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease | Q46778008 |
| | Isolation and culture of adult neurons and neurospheres | Q48147846 |
| | Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model | Q48250258 |
| | Altered PPARgamma expression and activation after transient focal ischemia in rats | Q48412142 |
| | Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. | Q51385320 |
| | A novel peroxisome proliferator-activated receptor responsive element-luciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver. | Q51774059 |
| | An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria | Q54965159 |
| | Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity | Q62397259 |
| | An animal model of oral dysphagia in amyotrophic lateral sclerosis. | Q64917474 |
| | A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group | Q72759362 |
| | Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients | Q77568620 |
| | Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS | Q80384279 |
| | Dyslipidemia is a protective factor in amyotrophic lateral sclerosis | Q80503053 |
| | Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production | Q80512821 |
| | PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model | Q82604791 |
| | Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis | Q82607328 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 35899-35911 | |
| P577 | publication date | 2012-08-21 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis | |
| P478 | volume | 287 | |